Finsbury Glover Hering Completes Merger and Buy-in and Announces Global Executive Leadership
Following their announcement on 7 July 2020, Finsbury, The Glover Park Group (GPG) and Hering Schuppener have completed their merger and management buy-in of 49.99 per cent of the combined business. The merger will create a pre-eminent global strategic communications and public affairs consultancy, operating from 18 offices with almost 700 consultants. WPP will remain a 50.01 per cent investor and Mark Read, CEO of WPP, will join the Board.
Over the past six months, the three firms have worked to integrate their operations and today announce global executive leadership teams, who will be charged with overseeing operations and driving growth across their regions.
Alexander Geiser serves as Global CEO and Regional CEO for Europe, Mike Feldman and Winnie Lerner as Regional Co-CEOs for North America and Faeth Birch as Regional CEO for the United Kingdom, Middle East and Asia. As previously announced, Carter Eskew and Roland Rudd are Co-Chairmen of the firm.
The merger of the three firms comes at a time when companies and organizations are navigating through an increasingly complex operating environment and balancing challenging social, political and economic dynamics. Finsbury Glover Hering will be a trusted partner to its clients, supporting their efforts to manage through these cross-currents and achieve their business goals. The combined entity will offer clients new reach across stakeholder audiences and geographies, allowing for fully-integrated communications campaigns.
Roland Rudd, Co-Chairman, said, “This is a great moment for Finsbury Glover Hering, we are all energised and excited by the opportunity to create a very special, owner-led firm and be an even better partner to our existing and new clients. We thank them for their support.”
“I am proud to have such a talented team leading our people across the world. I have worked with both Mike and Winnie for decades and have collaborated with Alex and Faeth on global projects over the years. The future of our global firm could not be in better hands,” said Carter Eskew, Co-Chairman.
Alexander Geiser, CEO, added: “We have received overwhelmingly positive feedback from clients and employees alike for this step. Both externally and internally, many have already experienced us as one firm. Now it has really become one firm – with a global brand, balance sheet and governance.”
About Finsbury Glover Hering
Finsbury Glover Hering is a new pre-eminent global strategic communications advisory firm, headquartered in New York City with almost 700 multidisciplinary experts across the world’s major financial, government, business and cultural centers. The company was formed through the merger of the leading strategic communications consultancies Finsbury, The Glover Park Group (GPG) and Hering Schuppener. The firm provides combined support in Business Transformation, Corporate Reputation & Leadership Strategies, Crisis & Issues Management, Government Relations & Policy and Advocacy as well as Transaction & Financial Communications, supported by research & insights, digital strategy, design and creative solutions.
Finsbury Glover Hering serves its global client base from offices in Abu Dhabi, Beijing, Berlin, Brussels, Dubai, Dublin, Düsseldorf, Frankfurt, Hong Kong, London, Los Angeles, Munich, New York, Riyadh, Shanghai, Singapore, Tokyo and Washington D.C.
Find more information visit www.fgh.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005217/en/
Contact information
Press contacts
USA
Ben Waldron
ben.waldron@fgh.com
+1 347 622 3740
UK
Dorothy Burwell
dorothy@fgh.com
+44 (20) 7251 3801
Europe
Dirk von Manikowsky
dirk.vonmanikowsky@fgh.com
+49 (211) 430 79 265
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines to Present at Upcoming Investor Conferences28.10.2025 12:01:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences: Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:00 pm GMT/11:00 am EST Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through
Allianz Reports Safety Gains From Automated Mobility and Urges EU-Wide “Driving License” for Autonomous Vehicles28.10.2025 11:05:00 EET | Press release
The promise of autonomous mobility is not just a technological leap – it represents a transformation in safety, comfort, and accessibility that is already underway with Level 3 vehicles on European roads and Level 4 systems operating in real-world test fields. At the 13th Allianz Motor Day in 2025, hosted by the Allianz Center for Technology (AZT), Allianz unveiled significant safety gains from autonomous vehicles and calls for EU-wide testing standards to ensure their safe integration into European roads, including questions about vehicle safety, liability, the use of in-vehicle data from autonomous vehicles (AVs), and more inclusive mobility. The company already insures test fields in several countries, including Germany, Norway, and Singapore. AZT research and proprietary claims analysis indicate a significant decline in motor liability claims frequency driven by advanced driver assistance systems (ADAS) now available in select models. While these systems already demonstrate impress
Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over €300 Million From Trei Real Estate28.10.2025 10:15:00 EET | Press release
Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, and Slate Asset Management (“Slate”), a global investor and manager focused on essential real estate and infrastructure, today announced that a joint venture between Ares Real Estate funds (“Ares Real Estate”) and Slate has agreed to acquire a portfolio of 36 properties in Poland (the “Portfolio”) from Trei Real Estate, an internationally active developer and asset manager. The Portfolio is valued at over €300 million. The Portfolio comprises 36 recently developed and fully occupied convenience-led retail parks strategically located across major Polish metropolitan areas near large catchment populations. The assets are inflation-protected through CPI-linked lease agreements underpinned by tenants with strong covenants. Most of the Portfolio’s income is derived from large regional retailers and essential goods providers, including grocers and pharmacies. “This transaction underlines our c
SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia28.10.2025 10:00:00 EET | Press release
SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green Lab certifications, including two at the program’s highest level, Green. The remaining two labs earned Gold certification, reflecting advanced sustainability performance and progression toward full Green maturity. The certified facilities are Small Molecule Europe (Swords, Ireland) and Small Molecule Asia (Daejeon, South Korea), and the certifications cover the areas of Quality Control, Process Research & Development, and Analytical Research & Development. My Green Lab certification is widely regarded as the global standard for laboratory sustainability, recognized by the United Nations Race to Zero campaign for its rigor in advancing credible decarbonization. Green certification is the program’s highest designation, reserved for laboratories that demonstrate exceptional, independently verif
Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing28.10.2025 08:00:00 EET | Press release
Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully completed a U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) and is now cleared for the commercial manufacturing and testing of injectable products destined for the U.S. market. This milestone marks the approval of the first product to get U.S. FDA clearance for commercial supply from Kemwell’s Bengaluru drug-product facility since the site became a dedicated biologics campus eight years ago. It demonstrates the company’s ability to meet stringent current Good Manufacturing Practice (cGMP) and aseptic drug-product manufacturing standards. “Achieving FDA clearance for commercial manufacturing from our Bengaluru site marks a defining moment in Kemwell’s growth journey,” said Anurag Bagaria, Chairman and CEO, Kemwell Biopharma. “It reflects our team’s ste
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
